EA
IPXL

Emerald Acquisition’s Impax Laboratories, Inc. IPXL Stock Holding History

Emerald Acquisition’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$7.66M Buy
323,207
+189,873
+142% +$5.1M 0.01% 983
2016
Q2 		$3.84M Buy
+133,334
New +$4.35M 0.01% 1491

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Emerald Acquisition's IPXL Position: Q3 2016 in Review

Emerald Acquisition increased its Impax Laboratories, Inc. (IPXL) stake by 142% in Q3 2016, buying an estimated $5.1M and bringing the position to 323,207 shares worth $7.66M. The position accounts for 0.01% of the portfolio, ranked #983.

Emerald Acquisition first reported a position in IPXL in Q2 2016 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Emerald Acquisition held 323,207 shares of Impax Laboratories, Inc. worth $7.66M as of Q3 2016.
  • Emerald Acquisition bought 189,873 Impax Laboratories, Inc. shares in Q3 2016, an estimated $5.1M.
  • Impax Laboratories, Inc. made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #983 holding.
  • Emerald Acquisition first reported a position in Impax Laboratories, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.